These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19805509)

  • 1. Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors.
    Rangel A; Sánchez-Armass S; Meza U
    Mol Pharmacol; 2010 Feb; 77(2):202-10. PubMed ID: 19805509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels.
    Meza U; Thapliyal A; Bannister RA; Adams BA
    Mol Pharmacol; 2007 Jan; 71(1):284-93. PubMed ID: 17050807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
    Tao J; Hildebrand ME; Liao P; Liang MC; Tan G; Li S; Snutch TP; Soong TW
    Mol Pharmacol; 2008 Jun; 73(6):1596-609. PubMed ID: 18292205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic M(1) modulation of N and L types of calcium channels is mediated by protein kinase C in neostriatal neurons.
    Perez-Burgos A; Perez-Rosello T; Salgado H; Flores-Barrera E; Prieto GA; Figueroa A; Galarraga E; Bargas J
    Neuroscience; 2008 Sep; 155(4):1079-97. PubMed ID: 18644425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors.
    Filippov AK; Fernández-Fernández JM; Marsh SJ; Simon J; Barnard EA; Brown DA
    Mol Pharmacol; 2004 Sep; 66(3):468-77. PubMed ID: 15322238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade.
    Day M; Olson PA; Platzer J; Striessnig J; Surmeier DJ
    J Neurophysiol; 2002 May; 87(5):2490-504. PubMed ID: 11976386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels.
    You H; Altier C; Zamponi GW
    Mol Pharmacol; 2010 Feb; 77(2):211-7. PubMed ID: 19864434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
    Choi KH; Rhim H
    Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of CaV2.3 Ca2+ channels by Galphaq/11-coupled muscarinic receptors.
    Bannister RA; Melliti K; Adams BA
    Mol Pharmacol; 2004 Feb; 65(2):381-8. PubMed ID: 14742680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion.
    Klose A; Huth T; Alzheimer C
    Mol Pharmacol; 2008 Nov; 74(5):1203-14. PubMed ID: 18682550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
    Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
    Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells.
    Kim Y; Park MK; Uhm DY; Chung S
    Biochem Biophys Res Commun; 2007 Jul; 358(3):796-801. PubMed ID: 17506983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.
    Ryzhov S; Goldstein AE; Biaggioni I; Feoktistov I
    Mol Pharmacol; 2006 Aug; 70(2):727-35. PubMed ID: 16707627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Purkinje cell specific GoLoco domain protein, L7/Pcp-2, modulates receptor-mediated inhibition of Cav2.1 Ca2+ channels in a dose-dependent manner.
    Kinoshita-Kawada M; Oberdick J; Xi Zhu M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):73-86. PubMed ID: 15548431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema.
    Claudino RF; Kassuya CA; Ferreira J; Calixto JB
    J Pharmacol Exp Ther; 2006 Aug; 318(2):611-8. PubMed ID: 16644903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin receptors inhibit G protein-coupled inwardly rectifying K+ channels expressed in Xenopus oocytes through a protein kinase C-dependent pathway.
    Stevens EB; Shah BS; Pinnock RD; Lee K
    Mol Pharmacol; 1999 Jun; 55(6):1020-7. PubMed ID: 10347243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
    Zheng M; Wang Y; Kang L; Shimaoka T; Marni F; Ono K
    J Mol Cell Cardiol; 2010 Jan; 48(1):131-9. PubMed ID: 19744490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-mediated inhibition of Cav3.2 T-type channels revisited.
    Perez-Reyes E
    Mol Pharmacol; 2010 Feb; 77(2):136-8. PubMed ID: 19903827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades.
    Gomes P; Soares-da-Silva P
    Eur J Pharmacol; 2004 Mar; 488(1-3):51-9. PubMed ID: 15044035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction underlying carbachol-induced contraction of human urinary bladder.
    Schneider T; Fetscher C; Krege S; Michel MC
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1148-53. PubMed ID: 14769832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.